A new study from Duke University researchers suggest treating teens for major depression could reduce their chances for developing drug or alcohol abuse problems later on.
The same gene variations that make it difficult to stop smoking also increase the likelihood that heavy smokers will respond to nicotine-replacement therapy and drugs that thwart cravings, a new study shows.
Addiction is on the rise in Europe. An increasing number of young people are unable to control their use of drugs, alcohol, sex, computer games, technology, shopping, dieting or exercise.
New research released in April’s American Journal of Public Health discovered anti-tobacco advertising does help reduce the need to spark up in adults, however only when the ads are from sponsors not associated with the tobacco industry. In states where anti-tobacco ads were sponsored by private initiatives, pharmaceutical and the state itself, the anti smoking message had greater impact. Ads created or sponsored directly by the tobacco industry prompted more smoking in states which ran these campaigns. However, although the anti-smoking ads delivered by pharmaceutical companies were more effective in getting people to smoke less, running ads for cessation products appear to have turned people off potentially quitting their addiction.
New research from Yale could help explain why cocaine addiction, abuse and dependency is dramatically increased in people who began using the drug during their teenage years, as opposed to later in adulthood.
Research undertaken by scientists at Baylor College of Medicine takes big steps in helping to explain why it is so hard for smokers to quit their addiction. Smoking enhances dopamine release, and when a smoker attempts to quit, dopamine levels lower significantly. The lapse in dopamine levels can prompt a relapse for smokers who are trying to quit. The authors suggest medications which could elevate dopamine levels when a smoker is trying to quit, could be key to a non-smoking life style and help to prevent relapse.
A new editorial released this week offers clarity and structure on confusing drug and alcohol addiction terminology for prescribers, users and regulators. “Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and alcohol treatments?” is published in the Journal of Psychopharmacology, the official journal of the British Association for Psychopharmacology, published by SAGE.
A new report from Yale researchers considers the different biological mechanisms associated with cocaine addiction between men and women. It is hoped that the study could shed some light onto effective therapies to help curb cravings, and ultimately break the addiction cycle based upon the sex of the patient. The findings so far suggest that women could benefit from stress reduction therapies, while men might benefit more from cognitive behavioral therapies or more traditional 12 step programs.